№ files_lp_3_process_9_01265
File format: docx Character count: 15380 File size: 263 KB
This document is a supplementary research material detailing the study of the association between GLP-1 receptor agonists and pneumonia incidence following endoscopic procedures.
Year: 2023
Region / City: Not specified
Subject: Medical research, Gastroenterology, Endoscopic Procedures
Document type: Research Supplement
Organization: Not specified
Author: Natalia Tejada, M.D., Ishak Mansi, M.D., Silvio W. de Melo Jr., M.D.
Target audience: Healthcare professionals, Researchers
Validity period: Not specified
Approval date: Not specified
Modification date: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Association of Glucagon-Like Peptide-1 Receptor Agonists with Serious Liver Events: A Scandinavian Cohort Study
Year: 2023
Region / city: Sweden, Denmark, Norway
Topic: Glucagon-like peptide-1 (GLP-1) receptor agonists, liver events, cohort study
Document type: Research study
Organization / institution: None specified
Author: Engström et al.
Target audience: Medical researchers, healthcare professionals
Period of validity: Not specified
Approval date: Not specified
Date of amendments: Not specified
ForwardHealth Prior Authorization Drug Attachment for Hypoglycemics, Glucagon-Like Peptide (GLP-1) Agents
Year: 2024
Region / City: Wisconsin
Theme: Healthcare / Medicaid
Document Type: Form
Organization / Institution: Department of Health Services, State of Wisconsin
Author: Department of Health Services
Target Audience: Healthcare providers, Prescribers, Pharmacy providers
Period of validity: Not specified
Approval Date: Not specified
Date of changes: Not specified
Association of Glucagon-Like Peptide-1 Receptor Agonists with Serious Liver Events: A Scandinavian Cohort Study
Year: 2023
Region / city: Sweden, Denmark, Norway
Topic: Glucagon-like peptide-1 (GLP-1) receptor agonists, liver events, cohort study
Document type: Research study
Organization / institution: None specified
Author: Engström et al.
Target audience: Medical researchers, healthcare professionals
Period of validity: Not specified
Approval date: Not specified
Date of amendments: Not specified
Association of Glucagon-Like Peptide-1 Receptor Agonists with Serious Liver Events: A Scandinavian Cohort Study
Year: 2023
Region / city: Sweden, Denmark, Norway
Topic: Glucagon-like peptide-1 (GLP-1) receptor agonists, liver events, cohort study
Document type: Research study
Organization / institution: None specified
Author: Engström et al.
Target audience: Medical researchers, healthcare professionals
Period of validity: Not specified
Approval date: Not specified
Date of amendments: Not specified
Table S1: Search Strategy for Web of Science Database on Cardiovascular Diseases and GLP-1 Receptor Agonists
Document type: Supplementary table
Database: Web of Science
Search platform: ISI
Content type: Search strategy
Research area: Cardiovascular diseases and GLP-1 receptor agonists
Keywords included: Cardiovascular diseases, cardiac events, heart failure, hypertension, myocardial ischemia, atherosclerosis, exenatide, liraglutide, dulaglutide, semaglutide, tirzepatide and related compounds
Search structure: Boolean operators with grouped synonyms
Purpose: Identification of relevant scientific literature
Excessive use of Short-acting beta 2 agonists (SABA) and its impact on asthma control
Year: 2024
Region / city: United Kingdom
Topic: Asthma treatment guidelines, drug safety
Document type: Guideline update
Organization / institution: NICE, SIGN, BTS
Author: National Health Service
Target audience: Healthcare professionals, asthma patients
Period of validity: 2024-2026
Approval date: 2024
Date of changes: 2025
Context: The document provides updated clinical guidelines and recommendations for reducing the overuse of Short-acting beta 2 agonists (SABA) in asthma management and emphasizes safer asthma treatment pathways.
Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favourable benefit-safety profile
Year: 2024
Region / City: International
Topic: Type 2 diabetes, Cardiovascular disease, GLP-1 receptor agonists
Document Type: Expert Opinion / Commentary
Organization / Institution: N/A
Author: Expert opinion
Target Audience: Healthcare professionals, Researchers
Period of Action: N/A
Date of Approval: N/A
Date of Changes: N/A
Keywords: Atherosclerotic cardiovascular disease, Cardiovascular outcome trial, GLP-1 receptor agonist, Observational studies, Real-world clinical practice
Topics: Peptide-1 Glucagon-Like Agonists